Navigation Links
Phalanx Biotech Group Reports Robust Revenue Growth in 2011
Date:3/5/2012

BELMONT, Calif., March 5, 2012 /PRNewswire/ -- Phalanx Biotech Group, a global genomic products and service provider, manufactures the OneArray® line of open-platform microarrays for whole genome gene expression and microRNA profiling.  Driven by several new product launches in 2011, Phalanx Biotech reported revenue growth across all its major geographical markets.  "2011 proved to be a very busy year for our manufacturing team with microarray launches of the Rat OneArray®, Rice OneArray®, and microRNA OneArray® and completion of several custom ODM projects," said Richard Su, Ph.D., Head of Product Development. "We anticipate 2012 to be equally busy with manufacturing runs already scheduled for an updated microRNA microarray and a focused cytogenetic microarray. Importantly, we continue to maintain a bullish stance on the utilization of microarrays for discovery research and clinical applications." 

"PhalanxBio, Inc., a wholly-owned, US subsidiary of Phalanx Biotech Group, achieved record 2011 sales in its target markets of North America and Europe – growing revenues more than 20% year over year," announced Shengwan Lee, Ph.D., President and CEO. "Our growth in this highly competitive marketplace is a strong testament by our customers of the performance and value of our OneArray® microarray products and services.  To underscore our commitment to delivering the highest quality products and services, I am also pleased to announce our recent ISO:9001:2008 and 13485:2003 certification – a validation of our adherence to the rigorous quality management systems at Phalanx Biotech."

About Phalanx Biotech Group

Phalanx Biotech Group, with operations in California, Taiwan and China, provides genomics products and services worldwide to academic, clinical, pharmaceutical and biotech communities. Built on world-class, integrated-chip foundry technology, Phalanx Biotech has developed the OneArray® line of high-quality and affordable microarrays for expression profiling of whole genomes (human, mouse, rat, yeast and rice), microRNA (human, mouse, rat and plant), and custom targets.  Our highly-trained service specialists provide a comprehensive offering of gene expression and microRNA profiling services for biomarker discovery including sample preparation, expression analysis, and qPCR validation. For more information about our products and services, please visit our website at www.phalanxbiotech.com.

Contact

Vivien  Mak, Ph.D., 1-650-320-8669 ext 103

vmak@onearray.com


'/>"/>
SOURCE Phalanx Biotech Group
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Phalanx Biotech Group Launches Rice Genome OneArray®
2. Biotech Firm Spun Off from Childrens Hospital Raises $7 Million to Advance Magnetic-Based Vascular Treatment
3. Global Biotechnology Industry
4. Wake Forest Baptist Medical Center Unveils Historic World-Class Biotech Research & Innovation Center in Downtown Winston-Salems Growing Piedmont Triad Research Park
5. JumpStart Invests $250,000 in Milo Biotechnology
6. Marina Biotech, Inc. Joins OTCQX
7. ConnectBiotech.org Launched, a Unique Life Science Business Networking Site
8. Neuralstem President and CEO to Update Ongoing ALS and NSI-189/Major Depressive Disorder Trials at 2012 Biotech Showcase
9. Chembio Presenting at Biotech Conference
10. Selexis SA to Present at Biotech Showcase 2012
11. Saladax Biomedical, Inc. to Present at Biotech Showcase™ 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/22/2016)... NEW YORK , June 22, 2016 /PRNewswire/ ... the growing next generation sequencing (NGS) market include ... adoption of smaller sequencers.  More accessible and affordable ... led to growing demand for consumables including sample ... The Market for Sample Preparation for Next ...
(Date:6/22/2016)... , June 22, 2016   ViaCyte, Inc. , ... stem cell-derived islet replacement therapy for the treatment of ... ISSCR 2016 Annual Meeting.  ISSCR 2016, the Global Stem ... at Moscone West in San Francisco.  ... presentations are as follows:Event: , Focus Session: Tools for ...
(Date:6/22/2016)... 2016  Mesa Biotech Inc., a privately-held, molecular ... designed specifically for point-of-care (POC) infectious disease diagnosis, ... board (SAB). Approved by the executive leadership team ... to advise on the development and commercialization of ... Dr. Steve Young , this world-class team ...
(Date:6/21/2016)... NANJING , China , June ... that a Phase 2 clinical trial for its novel ... statistically significant (p=0.023) and clinically meaningful pain relief against ... the United States , the trial enrolled 146 ... statistically significant (1) analgesia against placebo at week-1 (p=0.024), ...
Breaking Biology Technology:
(Date:4/28/2016)... First quarter 2016:   , ... the first quarter of 2015 The gross margin was ... 18.8) and the operating margin was 40% (-13) Earnings ... flow from operations was SEK 249.9 M (21.2) , ... SEK 7,000-8,500 M. The operating margin for 2016 is ...
(Date:4/15/2016)... -- A new partnership announced today will help life ... a fraction of the time it takes today, ... insurance policies to consumers without requiring inconvenient and ... rapid testing (A1C, Cotinine and HIV) and higi,s ... pulse, BMI, and activity data) available at local ...
(Date:3/31/2016)... BOCA RATON, Florida , March 31, 2016 /PRNewswire/ ... LEGX ) ("LegacyXChange" or the "Company") ... presentation for potential users of its soon to be ... The video ( https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also ... by the use of DNA technology to an industry ...
Breaking Biology News(10 mins):